Beta Bionics, Inc. · NASDAQ:BBNX

Feider Stephen sold 744 Beta Bionics, Inc. shares (Form 4)

Traded Nov 9, 2026 · Filed Nov 12, 2026

On Nov 9, 2026, Feider Stephen (Chief Financial Officer) sold 744 Beta Bionics, Inc. shares at US$17.00 for US$12,649 under a trading plan, leaving 159,378 shares. Filed Nov 12, 2026 (Form 4).

Sold
744 shares
Price
US$17.00
Value
US$12,649
Holding after
159,378 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 9, 2026Common StockOption exercise744US$5.10160,122Direct
Nov 9, 2026Common StockSale744US$17.00159,378Direct

Source

Download original · View original at SEC

Related